imipenem, anhydrous has been researched along with Communicable Diseases, Emerging in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bajaksouzian, S; Biek, D; Critchley, IA; Good, CE; Jacobs, MR; Jones, RN; Sader, HS; Windau, AR | 1 |
| Al Bayssari, C; Dabboussi, F; Hamze, M; Rolain, JM | 1 |
| Aminaka, M; Cui, L; Hiramatsu, K; Hori, S; Ito, T; Jin, J; Kaneko, K; Katayama, Y; Kobayashi, H; Kondo, S; Kurosawa, H; Nakamura, A; Oguri, T; Okuzumi, K; Yamakawa, J | 1 |
3 other study(ies) available for imipenem, anhydrous and Communicable Diseases, Emerging
| Article | Year |
|---|---|
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Communicable Diseases, Emerging; Drug Resistance, Multiple, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae; United States | 2010 |
Emergence of carbapenemase-producing Pseudomonas aeruginosa and Acinetobacter baumannii in livestock animals in Lebanon.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Communicable Diseases, Emerging; Genotype; Imipenem; Lebanon; Livestock; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2015 |
Heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) emerged before the clinical introduction of vancomycin in Japan: a retrospective study.
Topics: Anti-Bacterial Agents; Communicable Diseases, Emerging; Humans; Imipenem; Japan; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2012 |